SBRT Proves Mettle in Early, Inoperable Lung Cancer (CME/CE)

(MedPage Today) -- Superior local control, no increase in majority toxicity, longer OS with in stage I NSCLC

Source: MedPage Today Primary Care - February 25, 2019 Category: Primary Care Source Type: news